Alanna schepartz biography samples

Yale University. Click a cancer type below to learn more:. Many proteins that cause disease simply to bind to other proteins inside the cell. Protein drugs almost without exception carry out their tasks outside the cell, not within.

Alanna Schepartz was born and raised in New York City.

The beta-peptide inhibitors developed by Dr. Schepartz represent a new generation of anti-cancer drugs that are highly effective and specific in targeting almost any cancer-related protein-protein interaction. This new class of drugs may positively impact the treatment of almost half of all cancers. The Schepartz laboratory synthesized a series of peptide molecules that may provide a new therapeutic approach to inhibit EGFR — an important protein that is often mutated in non-small cell lung cancer.

The molecules can be used to inhibit even those forms of EGFR that are resistant to current therapies. Continued development of these new therapeutic agents could lead to new and more effective ways of treating patients whose lung cancer has already developed resistance to current therapies. Alanna Schepartz received her B. She then conducted postdoctoral work at the California Institute of Technology.

She joined the faculty at Yale in as an Assistant Professor, was promoted to the rank of Full Professor in , and was named a Sterling Professor in From to , Dr. She is the recipient of numerous awards including the Ralph F. Alanna Schepartz has also received numerous awards for teaching and service to the community. Select a Focus Area Below to learn more and see others working in these area.